# To Evaluate the Effect of Bacillus Subtilis Based Product in Gut Health and Immunomodulatory Effect in Healthy Adults.

> **NCT07377942** · NA · ENROLLING_BY_INVITATION · sponsor: **Bioagile Therapeutics Pvt. Ltd.** · enrollment: 46 (estimated)

## Conditions studied

- Healthy Participants Study

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotics (Bacillus Subtilis)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07377942
- **Lead sponsor:** Bioagile Therapeutics Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-16
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-05-10
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377942, "To Evaluate the Effect of Bacillus Subtilis Based Product in Gut Health and Immunomodulatory Effect in Healthy Adults.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07377942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*